dallas semaglutide nausea class action exposure and nausea. Data show the proportion of Weight Loss Drug Lawsuits in

It works by mimicking the naturally occurring hormone GLP-1, which regulates appetite and food intake by acting on receptors in the brain, pancreas, and gastrointestinal tract

Food and Drug Administration (FDA) in March 2024 and is recommended in the latest European Association for the Study of the Liver guidelines for MASLD with locally approved F2/F3 fibrosis

Tirzepatide acts on two receptors, GIP and GLP- 1 to provide better weight loss results and fewer side effects, as compared to Semaglutide

Table 16 for Study 7, and in Table 17 for Studies 8 and 9

An alternative approach aiming to maximize the efficacy of GLP-1 involves the delivery of nuclear receptor agonists to specific tissues characterized by the expression of GLP-1R

Source: Phase 2 trial data (Jastreboff et al., NEJM 2023)